Acadia Healthcare (ACHC) Expected to Post Quarterly Earnings on Tuesday

Acadia Healthcare (NASDAQ:ACHC) is expected to be posting its Q2 2026 results after the market closes on Tuesday, July 28th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $848.0850 million for the quarter. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Individuals may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. The company had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.40 EPS. On average, analysts expect Acadia Healthcare to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Acadia Healthcare Stock Down 0.2%

Shares of NASDAQ ACHC opened at $34.43 on Tuesday. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $34.90. The firm’s 50-day moving average is $26.97 and its 200-day moving average is $22.66. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a market capitalization of $3.17 billion, a PE ratio of -2.81, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. Royal Bank Of Canada raised their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Barclays increased their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. TD Cowen raised their price target on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. KeyCorp lifted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Finally, UBS Group upped their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $28.69.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in ACHC. EverSource Wealth Advisors LLC boosted its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN increased its position in shares of Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after buying an additional 1,510 shares in the last quarter. Prudential Financial Inc. raised its stake in Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after buying an additional 1,780 shares during the period. Glenmede Investment Management LP lifted its holdings in Acadia Healthcare by 15.6% during the third quarter. Glenmede Investment Management LP now owns 11,379 shares of the company’s stock worth $282,000 after acquiring an additional 1,532 shares in the last quarter. Finally, iSAM Funds UK Ltd acquired a new position in Acadia Healthcare in the third quarter valued at about $296,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.